Abstract
The metabolic and genic effects induced by a 20-fold lowering of carnitine content in the heart were studied in mildronate-treated rats. In the perfused heart, the proportion of palmitate taken up then oxidized was 5–10% lower, while the triacylglycerol (TAG) formation was 100% greater than in controls. The treatment was shown to increase the maximal capacity of heart homogenates to oxidize palmitate, the mRNA level of carnitine palmitoyltransferase I (CPT-I) isoforms, the specific activity of CPT-I in subsarcolemmal mitochondria and the total carnitine content of isolated mitochondria. Concomitantly, the increased mRNA expression of lipoprotein lipase, fatty acid translocase and enzymes of TAG synthesis was associated with a 5- and 2-times increase in serum TAG and free fatty acid contents, respectively. The compartmentation of carnitine at its main functional location was expected to allow the increased CPT-I activity to ensure in vivo correct fatty acid oxidation rates. All the inductions related to fatty acid transport, oxidation and esterification most likely stem from the abundance of blood lipids providing cardiomyocytes with more fatty acids.
Similar content being viewed by others
References
van der Vusse GJ, Glatz JF, Stam HC, Reneman RS: Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev 72: 881–940, 1992
Evans RD, Bennett MJ, Hauton D: Perfused heart studies to investigate lipid metabolism. Biochem Soc Trans 28: 113–120, 2000
Hoppel CL, Davis AT: Inter-tissue relationships in the synthesis and distribution of carnitine. Biochem Soc Trans 14: 673–674, 1986
Paulson DJ: Carnitine deficiency-induced cardiomyopathy. Mol Cell Biochem 180: 33–41, 1998
Martin MA, Gomez MA, Guillen F, Bornstein B, Campos Y, Rubio JC, de la Calzada CS, Arenas J: Myocardial carnitine and carnitine palmitoyltransferase deficiencies in patients with severe heart failure. Biochim Biophys Acta 1502: 330–336, 2000
Esser V, Britton CH, Weis BC, Foster DW, McGarry JD: Cloning, sequencing, and expression of a cDNA encoding rat liver carnitine palmitoyltransferase I. Direct evidence that a single polypeptide is involved in inhibitor interaction and catalytic function. J Biol Chem 268: 5817–5822, 1993
Britton CH, Schultz RA, Zhang B, Esser V, Foster DW, McGarry JD: Human liver mitochondrial carnitine palmitoyltransferase I: Characterization of its cDNA and chromosomal localization and partial analysis of the gene. Proc Natl Acad Sci USA 92: 1984–1988, 1995
Esser V, Brown NF, Cowan AT, Foster DW, McGarry JD: Expression of a cDNA isolated from rat brown adipose tissue and heart identifies the product as the muscle isoform of carnitine palmitoyltransferase I (M-CPT I). M-CPT I is the predominant CPT I isoform expressed in both white (epididymal) and brown adipocytes. J Biol Chem 271: 6972–6977, 1996
Sul HS, Wang D: Nutritional and hormonal regulation of enzymes in fat synthesis: Studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription. Annu Rev Nutr 18: 331–351, 1998
Andersson M, Wettesten M, Boren J, Magnusson A, Sjoberg A, Rustaeus S, Olofsson SO: Purification of diacylglycerol:acyltransferase from rat liver to near homogeneity. J Lipid Res 35: 535–545, 1994
Swanton EM, Saggerson ED: Glycerolipid metabolizing enzymes in rat ventricle and in cardiac myocytes. Biochim Biophys Acta 1346: 93–102, 1997
Bjerve KS, Daae LN, Bremer J: Phosphatidic acid biosynthesis in rat liver mitochondria and microsomal fractions. Regulation of fatty acid positional specificity. Biochem J 158: 249–254, 1976
Cook GA, Park EA: Expression and regulation of carnitine palmitoyltransferase-Ialpha and-Ibeta genes. Am J Med Sci 318: 43–48, 1999
Brandt JM, Djouadi F, Kelly DP: Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha. J Biol Chem 273: 23786–23792, 1998
Abumrad N, Coburn C, Ibrahimi A: Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPpm. Biochim Biophys Acta 1441: 4–13, 1999
Simkhovich BZ, Shutenko ZV, Meirena DV, Khagi KB, Mezapuke RJ, Molodchina TN, Kalvins IJ, Lukevics E: 3-(2,2,2-Trimethylhydrazinium) propionate (THP) — a novel gamma-butyrobetaine hydroxylase inhibitor with cardioprotective properties. Biochem Pharmacol 37: 195–202, 1988
McGarry JD, Foster DW: An improved and simplified radioisotopic assay for the determination of free and esterified carnitine. J Lipid Res 17: 277–281, 1976
Folch J, Lees M, Sloane-Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497–509, 1957
Niot I, Pacot F, Bouchard P, Gresti J, Bernard A, Bezard J, Clouet P: Involvement of microsomal vesicles in part of the sensitivity of carnitine palmitoyltransferase I to malonyl-CoA inhibition in mitochondrial fractions of rat liver. Biochem J 304: 577–584, 1994
Belfrage P, Vaughan M: Simple liquid—liquid partition system for isolation of labeled oleic acid from mixtures with glycerides. J Lipid Res 10: 341–344, 1969
Mantha L, Palacios E, Deshaies Y: Modulation of triglyceride metabolism by glucocorticoids in diet-induced obesity. Am J Physiol 277: R455–464, 1999
Veerkamp JH, Van Moerkerk HT, Glatz JF, Van Hinsbergh VW: Incomplete palmitate oxidation in cell-free systems of rat and human muscles. Biochim Biophys Acta 753: 399–410, 1983
Palmer JW, Tandler B, Hoppel CL: Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle. J Biol Chem 252: 8731–8739, 1977
Pande SV, Parvin R: Characterization of carnitine acylcarnitine translocase system of heart mitochondria. J Biol Chem 251: 6683–6691, 1976
Bremer J: The effect of fasting on the activity of liver carnitine palmitoyltransferase and its inhibition by malonyl-CoA. Biochim Biophys Acta 665: 628–631, 1981
Clouet P, Henninger C, Pascal M, Bezard J: High sensitivity of carnitine acyltransferase I to malonyl-CoA inhibition in liver of obese Zucker rats. FEBS Lett 182: 331–334, 1985
Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC: Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76–85, 1985
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159, 1987
Broderick TL, Christos SC, Wolf BA, DiDomenico D, Shug AL, Paulson DJ: Fatty acid oxidation and cardiac function in the sodium pivalate model of secondary carnitine deficiency. Metabolism 44: 499–505, 1995
Morris GS, Zhou Q, Wolf BA, Christos SC, DiDomenico DF, Shug AL, Paulson DJ: Sodium pivalate reduces cardiac carnitine content and increases glucose oxidation without affecting cardiac functional capacity. Life Sci 57: 2237–2244, 1995
Evans JR, Opie LH, Shipp JC: Metabolism of palmitic acid in perfused rat heart. Am J Physiol 205: 766–770, 1963
Oram JF, Bennetch SL, Neely JR: Regulation of fatty acid utilization in isolated perfused rat hearts. J Biol Chem 248: 5299–5309, 1973
Katz AM, Messineo FC: Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circ Res 48: 1–16, 1981
Liedtke AJ, DeMaison L, Eggleston AM, Cohen LM, Nellis SH: Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium. Circ Res 62: 535–542, 1988
McGarry JD, Meier JM, Foster DW: The effects of starvation and refeeding on carbohydrate and lipid metabolism in vivo and in the perfused rat liver. The relationship between fatty acid oxidation and esterification in the regulation of ketogenesis. J Biol Chem 248: 270–278, 1973
Bontemps L, Demaison L, Dubois F, Pernin C, Mathieu JP, Vidal M, Comet M, Cuchet P: A new experimental model for studies of drug actions on myocardial metabolism. Application to a study of the influence of POCA. Int J Rad Appl Instrum B 14: 459–465, 1987
Luiken JJ, van Nieuwenhoven FA, America G, van der Vusse GJ, Glatz JF: Uptake and metabolism of palmitate by isolated cardiac myocytes from adult rats: Involvement of sarcolemmal proteins. J Lipid Res 38: 745–758, 1997
Erskine JM, Jensen DR, Eckel RH: Macronutrient regulation of lipoprotein lipase is posttranslational. J Nutr 124: 500–507, 1994
Ong JM, Simsolo RB, Saghizadeh M, Goers JW, Kern PA: Effects of exercise training and feeding on lipoprotein lipase gene expression in adipose tissue, heart, and skeletal muscle of the rat. Metabolism 44: 1596–1605, 1995
Borensztajn J, Rone MS, Babirak SP, McGarr JA, Oscai LB: Effect of exercise on lipoprotein lipase activity in rat heart and skeletal muscle. Am J Physiol 229: 394–397, 1975
Vaziri ND, Liang K, Barton CH: Effect of increased afterload on cardiac lipoprotein lipase and VLDL receptor expression. Biochim Biophys Acta 1436: 577–584, 1999
Weis BC, Esser V, Brown N, Foster DW, McGarry JD: Rat heart expresses two forms of mitochondrial carnitine palmitoyltransferase I. J Biol Chem 269: 18712–18715, 1994
Yamazaki N, Shinohara Y, Shima A, Terada H: High expression of a novel carnitine palmitoyltransferase I like protein in rat brown adipose tissue and heart: Isolation and characterization of its cDNA clone. FEBS Lett 363: 41–45, 1995
Brown NF, Weis BC, Husti JE, Foster DW, McGarry JD: Mitochondrial carnitine palmitoyltransferase I isoform switching in the developing rat heart. J Biol Chem 270: 8952–8957, 1995
Robles-Valdes C, McGarry JD, Foster DW: Maternal-fetal carnitine relationship and neonatal ketosis in the rat. J Biol Chem 251: 6007–6012, 1976
Chien D, Dean D, Saha AK, Flatt JP, Ruderman NB: Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo. Am J Physiol Endocrinol Metab 279: E259–265, 2000
Kent C: CTP:phosphocholine cytidylyltransferase. Biochim Biophys Acta 1348: 79–90, 1997
Nielsen LB, Veniant M, Boren J, Raabe M, Wong JS, Tam C, Flynn L, Vanni-Reyes T, Gunn MD, Goldberg IJ, Hamilton RL, Young SG: Genes for apolipoprotein B and microsomal triglyceride transfer protein are expressed in the heart: Evidence that the heart has the capacity to synthesize and secrete lipoproteins. Circulation 98: 13–16, 1998
Boren J, Veniant MM, Young SG: Apo B100-containing lipoproteins are secreted by the heart. J Clin Invest 101: 1197–1202, 1998
Bonen A, Dyck DJ, Ibrahimi A, Abumrad NA: Muscle contractile activity increases fatty acid metabolism and transport and FAT/CD36. Am J Physiol 276: E642–649, 1999
Ibrahimi A, Bonen A, Blinn WD, Hajri T, Li X, Zhong K, Cameron R, Abumrad NA: Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J Biol Chem 274: 26761–26766, 1999
Luiken JJFP, Arumugam Y, Dyck DJ, Bell RC, Pelsers MML, Turcotte LP, Tandon NN, Glatz JFC, Bonen A: Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J Biol Chem 276: 40567–40573, 2001
Watkins PA, Lu JF, Steinberg SJ, Gould SJ, Smith KD, Braiterman LT: Disruption of the Saccharomyces cerevisiae FAT1 gene decreases very long-chain fatty acyl-CoA synthetase activity and elevates intracellular very long-chain fatty acid concentrations. J Biol Chem 273: 18210–18219, 1998
Coe NR, Smith AJ, Frohnert BI, Watkins PA, Bernlohr DA: The fatty acid transport protein (FATP1) is a very long chain acyl-CoA synthetase. J Biol Chem 274: 36300–36304, 1999
Storch J, Thumser AE: The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta 1486: 28–44, 2000
Glatz JF, van der Vusse GJ: Intracellular transport of lipids. Mol Cell Biochem 88: 37–44, 1989
Amri EZ, Bertrand B, Ailhaud G, Grimaldi P: Regulation of adipose cell differentiation. I. Fatty acids are inducers of the aP2 gene expression. J Lipid Res 32: 1449–1456, 1991
Hertzel AV, Bernlohr DA: Regulation of adipocyte gene expression by polyunsaturated fatty acids. Mol Cell Biochem 188: 33–39, 1998
Keller H, Mahfoudi A, Dreyer C, Hihi AK, Medin J, Ozato K, Wahli W: Peroxisome proliferator-activated receptors and lipid metabolism. Ann NY Acad Sci 684: 157–173, 1993
van der Lee KA, Vork MM, De Vries JE, Willemsen PH, Glatz JF, Reneman RS, Van der Vusse GJ, Van Bilsen M: Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes. J Lipid Res 41: 41–47, 2000
Muoio DM, Seefeld K, Witters LA, Coleman RA: AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: Evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem J 338: 783–791, 1999
Schoonjans K, Staels B, Auwerx J: Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37: 907–925, 1996
Motojima K, Passilly P, Peters JM, Gonzalez FJ, Latruffe N: Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue-and inducer-specific manner. J Biol Chem 273: 16710–16714, 1998
Cook WS, Yeldandi AV, Rao MS, Hashimoto T, Reddy JK: Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha. Biochem Biophys Res Commun 278: 250–257, 2000
Tsoko M, Beauseigneur F, Gresti J, Niot I, Demarquoy J, Boichot J, Bezard J, Rochette L, Clouet P: Enhancement of activities relative to fatty acid oxidation in the liver of rats depleted of L-carnitine by D-carnitine and a gamma-butyrobetaine hydroxylase inhibitor. Biochem Pharmacol 49: 1403–1410, 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Degrace, P., Demizieux, L., Gresti, J. et al. Fatty acid oxidation and related gene expression in heart depleted of carnitine by mildronate treatment in the rat. Mol Cell Biochem 258, 171–182 (2004). https://doi.org/10.1023/B:MCBI.0000012853.20116.06
Issue Date:
DOI: https://doi.org/10.1023/B:MCBI.0000012853.20116.06